This study found that Polybromo‐1 (PBRM1) sensitizes renal cell carcinoma (RCC) to immunotherapy through regulating macrophage‐associated chemokines and increasing M1 macrophage infiltration. Here, PBRM1 is linked to renal cell adenocarcinoma.